Medical Pharmacology Chapter 40: Abnormal Immune Responses
Hypersensitivity
Excessive response may lead to significant tissue damage
Autoimmunity
Immunoreactivity against "self" antigens
Immunodeficiency
Diminished reactivity
Classification: Determined by time required for expression of clinical symptoms following antigen exposure:
Immediate Hypersensitivity or Delayed
Immediate Hypersensitivity: antibody mediated; symptoms occurring within minutes to a few hours following antigen exposure: Three Categories:
Antigen cross-linking of membrane-bound IgE on blood basophils or tissue mast cells
Cellular Degranulation: releasing histamine, leukotrienes, and other mediators)
These mediators may induce:
Asthma
|
|
Hives
Hay fever
Antigen-antibody complex formation between foreign antigen +IgM or IgG immunoglobulins
Examples:
Hashimoto's thyroiditis
|
|
Hashimoto's thyroiditis
|
|
Blood transfusion reactions
Newborn: hemolytic disease
Mechanism:
Antibodies formed «foreign erythrocyte membrane antigens
Drug Induced
Complement cascade activation
Generation of membrane attack complex ® destroys red blood cells
Anti-Rh IgG antibodies (produced by an Rh negative mother):
Cross the placenta
Bind to erythrocytes of Rh-positive fetus;damage fetal erythrocytes
Administration of anti-Rh antibodies to the mother; 24-48 hours after delivery of the first Rh+ child
Penicillin administration to allergic patients
Mechanism: penicillin binds to erythrocytes or other host tissue leading to neoantigen production of antibodies followed by induction complement-mediated cell lysis
Repeat administration may causesystemic anaphylaxis
Presence of increased antigen-antibody complex concentrations may lead to tissue damage
Example: polyarteritis
|
|
Complexes activate complement producing components with:
Anaphylatoxic / chemotactic actions (C5a, C3a, C4a) which:
Increase vascular permeability
Attract neutrophils to the site of complex deposition
Complex deposition; neutrophil-release of lytic enzymes may cause:
Skin rash
Glomerulonephritis
Arthritis
Cell-mediated;
Responses: 2-3 days after sensitizing antigen exposure
Tissue Characteristics:
Local inflammatory response
Significant damage associated with influx of antigen-nonspecific inflammatory cells especially neutrophils and macrophages
Macrophage/Neutrophil Recruitment -- mediation:
Extravasation and chemotaxis of neutrophils and circulating monocytes
Induction of myelopoiesis
Macrophage activation causing enhanced:
Phagocytic
Microbicidal activity
Antigen-presenting functions
Eigestive enzyme release, contributing to extensive tissue damage
Delayed-type hypersensitivity however are very effective in combating/eliminating infections caused by intracellular pathogens:
M. tuberculosis
Leishmania
Failure to distinguish "self" tissues and cells from foreign ("nonself") antigens
Caused by activation of self-reactive T and B lymphocytes which induce:
Cell-mediated responses against self antigens
Humoral immune responses against self antigens
Clinical Pathologic Consequences, Autoimmune Disease: Examples
IgM antibodies (rheumatoid factors) react with Fc IgG component to form immune complexes.
Immune complexes ®split complement components ® joint and kidney inflammation
Systemic lupus erythematosus
|
|
Antibodies produced against:
Self DNA
Red blood cells
Platelets
Histones
Insulin-dependent diabetes mellitus
|
|
Cell-mediated
Insulin-producing
pancreatic B cells
Activated CD4+ TDTH
:
Infiltrate
islets of Langerhans
Recognize self
islet B-cell peptides
Possible Explanations for Autoimmune Disease:
Self-reactive T cell exposure to previously unseen antigens (e.g. myelin basic protein, lens protein)
Molecular mimicry in which
immune responses are directed against
pathogenic antigenic determinants sharing
identical or very similar epitopes with
normal host tissue -- example: Rheumatic
fever following Streptococcus pyrogenes infection-- heart
muscle damage secondary to
host-immune responses against
streptococcal antigenic
determinants shared with
myocardial tissue In the
case of viral etiology --
cell-mediated and humoral immune
responses are directed against
viral epitopes mimicking
sequestered self antigens
Inappropriate class II MHC molecular expression on cell membranes that should not and normally do not expressed class II MHC (pancreatic islet B cells)
B cells then present "self" peptides to helper T cells ® induce CTL, TDTH, and B lymphocyte cells ® react against self antigens
Primary Source: Barbuto, J.A.M, Akporiaye, E.T. and Hersh, E.M. Immunopharmacology, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 916-940
Haynes, B. F., Fauci, A.S. Disorders of the Immune System, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 1753-1776.
Carpenter, C. B. The Major Histocompatibility Gene Complex, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 1777-1782.
Cooper,M.D, and Lawton III, A. R. Primary Immune Deficiency Diseases, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 1783-1791
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |